Dr. Reddy's Laboratories Ltd

RDY Healthcare Drug Manufacturers Specialty & Generic

Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025.

Revenue
−10.1%
EPS
−36.8%
Free cash flow
−70.5%
Total debt
+14.1%

Quarter to September 2026, against a year earlier

14.84 0.31 +2.13%
Market cap
$12.1B
P/E
44.4×
Fwd P/E
30.7×
Dividend yield
0.00%
F-score
4/9
Altman Z
5.26
Beneish M
−2.59
Dividend safety
74/100
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Piotroski F-Score
4 2 6 8 6 5 7 8 5 5
P/E ratio
25.79 19.98 18.30 17.10 29.88 43.04 24.60 25.19 35.22 36.83
Altman Z-Score
5.26 5.94 8.43 7.87 6.38 7.07 6.30 5.35 3.86 4.33
P/S ratio
3.22 2.88 3.67 3.16 3.27 3.93 2.89 3.02 2.46 3.08
Altman Z″-Score (non-manufacturers)
6.10 6.93 8.73 8.51 6.56 6.32 6.70 5.81 4.50 3.84
P/FCF ratio
53.62 69.98 53.50 19.42 56.74 32.12 20.90 20.76 49.30 0.00
P/Operating CF
77.38 42.42 89.82 39.07 80.42 66.55 477.74 67.96 63.22 47.79
Beneish M-Score
(2.59) (1.97) (2.25) (2.68) (2.38) (2.78) (2.56) (2.73) (2.62) (2.46)
Dividend Safety Score
74 — — — — — — — — —
P/B ratio
2.84 2.78 3.66 3.36 3.68 4.30 3.25 3.32 2.76 3.50
EV/Sales
3.19 2.85 3.45 2.96 3.21 3.90 2.86 3.11 2.67 3.30
EV/EBITDA
15.04 10.41 11.68 10.43 16.67 16.20 11.04 14.48 16.05 18.76
EV/FCF
53.09 69.10 50.29 18.18 55.73 31.88 20.70 21.36 53.45 (23.96)
Current Ratio
1.80 1.92 2.58 2.41 1.93 1.78 1.79 1.92 1.57 1.18
Net Debt/EBITDA
(0.15) (0.13) (0.75) (0.71) (0.30) (0.12) (0.10) 0.40 1.25 1.24
Debt/Equity
0.20 0.14 0.07 0.06 0.18 0.18 0.14 0.27 0.40 0.40
ROE
11.40% 18.13% 21.63% 20.60% 12.76% 10.68% 12.69% 13.70% 7.83% 9.66%
ROA
7.63% 12.72% 15.60% 14.09% 8.30% 7.03% 8.17% 8.09% 4.41% 5.70%
ROIC
8.55% 13.82% 19.31% 19.68% 10.36% 12.25% 13.64% 8.51% 4.78% 5.45%
Return on Tangible Assets
17.09% 26.05% 24.32% 24.00% 15.73% 14.15% 17.78% 17.27% 10.05% 16.64%
Average Days of Receivables
110.01 101.33 104.92 107.60 113.66 95.54 105.12 94.49 104.43 98.69
Earnings Yield
3.88% 5.00% 5.46% 5.85% 3.35% 2.32% 4.06% 3.97% 2.84% 2.71%
Free Cash Flow Yield
1.86% 1.43% 1.87% 5.15% 1.76% 3.11% 4.78% 4.82% 2.03% (4.47%)
Free Cash Flow per Share
0.26 0.19 0.28 0.59 0.20 0.38 0.39 0.39 0.13 (0.36)
Book value per Share
4.87 4.74 4.05 3.38 3.03 2.85 2.48 2.44 2.34 2.30
Free Cash Flow
215.00 157.00 230.00 487.00 163.00 317.00 320.00 324.00 109.00 (299.00)
EV/EBIT
21.18 12.88 14.24 12.74 23.35 22.51 15.23 22.91 31.84 34.45
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026